Retour
Fourchette du Jour
8,95 €
11,00 €
Fourchette 52 Semaines
8,95 €
12,95 €
Volume
100
Moyenne 50J / 200J
11,67 €
/
12,63 €
Clôture Précédente
8,95 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 12,3 | 0,3 |
| P/B | 1,9 | 2,9 |
| ROE % | 16,4 | 3,7 |
| Net Margin % | 7,2 | 3,8 |
| Rev Growth 5Y % | 2,6 | 10,0 |
| D/E | 1,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,12 €
1,07 € – 1,21 €
|
1,6 B | 1 |
| FY2028 |
1,15 €
1,10 € – 1,24 €
|
1,6 B | 1 |
| FY2027 |
1,06 €
1,02 € – 1,15 €
|
1,5 B | 1 |
Points Clés
Revenue grew 2,58% annually over 5 years — modest growth
Earnings grew 29,10% over the past year
ROE of 16,35% — decent returns on equity
Generating 156,34M in free cash flow
P/E of 12,25 — trading at a low valuation
PEG of 0,54 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
2,58%
Revenue (1Y)-4,60%
Earnings (1Y)29,10%
FCF Growth (3Y)15,60%
Qualité
Return on Equity
16,35%
ROIC7,82%
Net Margin7,24%
Op. Margin10,76%
Sécurité
Debt / Equity
1,26
Current Ratio0,64
Interest Coverage6,25
Valorisation
P/E Ratio
12,25
P/B Ratio1,94
EV/EBITDA13,04
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,60% | Revenue Growth (3Y) | -0,31% |
| Earnings Growth (1Y) | 29,10% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,58% | Earnings Growth (5Y) | 3,55% |
| Profitability | |||
| Revenue (TTM) | 1,28B | Net Income (TTM) | 92,57M |
| ROE | 16,35% | ROA | 6,43% |
| Gross Margin | 21,09% | Operating Margin | 10,76% |
| Net Margin | 7,24% | Free Cash Flow (TTM) | 156,34M |
| ROIC | 7,82% | FCF Growth (3Y) | 15,60% |
| Safety | |||
| Debt / Equity | 1,26 | Current Ratio | 0,64 |
| Interest Coverage | 6,25 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 12,25 | P/B Ratio | 1,94 |
| P/S Ratio | 0,89 | PEG Ratio | 0,54 |
| EV/EBITDA | 13,04 | Dividend Yield | 0,04% |
| Market Cap | 1,13B | Enterprise Value | 1,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,28B | 1,34B | 1,29B | 1,26B | 1,15B |
| Net Income | 92,57M | 71,70M | -42,20M | 24,40M | 80,50M |
| EPS (Diluted) | 0,73 | 0,57 | -0,33 | 0,19 | 0,63 |
| Gross Profit | 269,60M | 790,20M | 303,20M | 733,40M | 665,80M |
| Operating Income | 137,55M | 116,10M | -14,70M | 33,90M | 110,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,44B | 1,40B | 1,42B | 1,48B | 1,45B |
| Total Liabilities | 856,68M | 850,20M | 904,10M | 887,40M | 839,70M |
| Shareholders' Equity | 583,98M | 548,20M | 515,40M | 592,00M | 608,90M |
| Total Debt | 734,82M | 570,00M | 635,80M | 607,00M | 557,30M |
| Cash & Equivalents | 75,17M | 65,20M | 37,70M | 40,20M | 38,10M |
| Current Assets | 207,62M | 208,20M | 192,60M | 189,70M | 172,80M |
| Current Liabilities | 326,08M | 312,50M | 300,30M | 306,90M | 392,00M |